EntryPoint Capital’s Protagonist Therapeutics PTGX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-3,696	Closed	-$84.7K	–	1693
2023 Q4	$84.7K	Buy	+3,696	New	+$84.7K	0.08%	463